The CARDIOPAT brand, founded in 2004 (United States), from 39 sister brands and 4472 competing brands. CARDIOPAT is a brand of Haemonetics Co., listed on the stock exchange of New York. CARDIOPAT belongs to the Medical Devices & Instruments business sector.
Investment simulator :
Portfolio valuation
Haemonetics Co.
(CARDIOPAT)
over 5 years*
USD 91.64